ApHER has entered a new cooperation with EasyTrial ApS and IWA Consulting ApS. This cooperation aims to support our customers throughout the several phases of Medical Device production by offering qualified advice and guidance in respect of regulatory compliance. This is especially important due to the new European Medical Device Regulation 2017/745, which will come into [...]
MedEngine acquires ApHER to offer Nordic real-world data solutions to global pharmaceutical companies
Helsinki, Finland – March 4th, 2021. MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company. The companies will combine their scientific expertise and profound understanding of Nordic health data to provide advanced real-world data solutions to the global pharmaceutical industry. [...]
ApHER presented a poster “Treatment patterns and survival for small cell lung cancer patients: A nationwide Danish register study” at the annual meeting of the European Society for Medical Oncology, ESMO2020, held as a virtual event 17-20 September 2020. Check also these articles (in Danish) on our work in Dagens Medicin and Onkologisk Tidsskrift: Article in [...]
Take a look at our most recent publication published in the journal BMC Cardiovascular Disorders. The study aimed to evaluate low-density lipoprotein cholesterol goal attainment and lipid-lowering therapy intensity in patients with coronary syndrome in order to reduce the risk of further cardiac events. You can read the abstract below or follow this link to read [...]
Who we are ApHER is an independent academic research organization and partner of the EnCEPP network. ApHER has provided evidence based research for decision making in the health care system, medical device and pharmaceutical development policy since 2009. We are your long term trusted partner. We conduct research and analyses which will provide decision support [...]
Have a look at our most recent publication published in the Pharmacoepidemiology & Drug Safety journal. The study combines Nordic register data from Denmark, Finland and Sweden with the purpose of comparing users of Finasteride treatment with nonusers. You can read the abstract below, or follow this link to order access to the full article. Abstract [...]
Prof. Anders Green – Appointed Member of the International Scientific Board of the Dasman Diabetes Institute
As of April 1st 2020, Professor Anders Green has been appointed Member of the International Scientific Board of the Dasman Diabetes Institute, Kuwait. The Institute is one of the leading centres in the Middle East for treatment, training and research in diabetes which constitutes a dramatically rising and alarming health problem in the region. As a [...]
ApHER has presented results from the CEDAR Study in the poster “The past, present, and future of prostate cancer incidence, mortality and prevalence in Denmark during 2006 through 2030” at the 11th European Multidisciplinary Congress on Urological Cancer (EMUC19) 15-17 November, 2019.
Last week ApHER participated at the 2nd Project Meeting of the Horizon2020 WOOL2LOOP Project hosted by Ergon in Lier, Belgium. It has been a pleasure to meet the partners of the consortium implementing circular economy of construction materials.
Thanks for the large attendance during our breakout session at ISPOR in Copenhagen regarding pooling Nordic register data! We find it rewarding to share our experiences and our extensive know-how from 10 years of doing these unique studies. ApHER also presented two posters during the conference, using Danish data on Sclerosis in one study and Swedish [...]